Literature DB >> 10722429

Association between resistance to vancomycin and death in cases of Enterococcus faecium bacteremia.

J M Garbutt1, M Ventrapragada, B Littenberg, L M Mundy.   

Abstract

We conducted a retrospective cohort study to determine the association between resistance to vancomycin and mortality among hospitalized patients with Enterococcus faecium bacteremia. We compared outcomes for patients infected with vancomycin-resistant versus vancomycin-susceptible E. faecium among 69 patients with bacteremia defined according to the National Nosocomial Infections Surveillance system. The univariate odds ratio (OR) for death associated with vancomycin resistance was 2.1 (P=.172). After controlling for severity of illness, we found that vancomycin resistance was not associated with mortality (OR, 1.74; 95% confidence interval, 0.5-6.12; P=.39). Vancomycin resistance does not independently increase mortality among patients with E. faecium bacteremia.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10722429     DOI: 10.1086/313694

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  25 in total

Review 1.  What action should be taken to prevent spread of vancomycin resistant enterococci in European hospitals?

Authors:  Ben Ridwan; Ellen Mascini; Netty van Der Reijden; Jan Verhoef; Marc Bonten
Journal:  BMJ       Date:  2002-03-16

2.  Association between vancomycin-resistant Enterococci bacteremia and ceftriaxone usage.

Authors:  James A McKinnell; Danielle F Kunz; Eric Chamot; Mukesh Patel; Rhett M Shirley; Stephen A Moser; John W Baddley; Peter G Pappas; Loren G Miller
Journal:  Infect Control Hosp Epidemiol       Date:  2012-05-14       Impact factor: 3.254

Review 3.  Relationships between enterococcal virulence and antimicrobial resistance.

Authors:  L M Mundy; D F Sahm; M Gilmore
Journal:  Clin Microbiol Rev       Date:  2000-10       Impact factor: 26.132

4.  Observational study of the epidemiology and outcomes of vancomycin-resistant Enterococcus bacteraemia treated with newer antimicrobial agents.

Authors:  J A McKinnell; M Patel; R M Shirley; D F Kunz; S A Moser; J W Baddley
Journal:  Epidemiol Infect       Date:  2010-11-15       Impact factor: 2.451

5.  Vancomycin-resistant enterococci in Canada revisited.

Authors:  B L Johnston; J M Conly
Journal:  Can J Infect Dis       Date:  2000-05

Review 6.  Hospital epidemiology and infection control in acute-care settings.

Authors:  Emily R M Sydnor; Trish M Perl
Journal:  Clin Microbiol Rev       Date:  2011-01       Impact factor: 26.132

7.  Sequential emergence of antibiotic resistance in enterococcal bloodstream isolates over 25 years.

Authors:  David R Murdoch; Stanley Mirrett; Lizzie J Harrell; Janet S Monahan; L Barth Reller
Journal:  Antimicrob Agents Chemother       Date:  2002-11       Impact factor: 5.191

8.  Peptide nucleic acid fluorescent in situ hybridization for hospital-acquired enterococcal bacteremia: delivering earlier effective antimicrobial therapy.

Authors:  Graeme N Forrest; Mary-Claire Roghmann; Latoya S Toombs; Jennifer K Johnson; Elizabeth Weekes; Durry P Lincalis; Richard A Venezia
Journal:  Antimicrob Agents Chemother       Date:  2008-07-28       Impact factor: 5.191

9.  Vancomycin-resistant enterococcal bacteremia in a hematology unit: molecular epidemiology and analysis of clinical course.

Authors:  Jin-Hong Yoo; Dong-Gun Lee; Su Mi Choi; Jung-Hyun Choi; Wan-Shik Shin; Myungshin Kim; Dongeun Yong; Kyungwon Lee; Woo-Sung Min; Chun-Choo Kim
Journal:  J Korean Med Sci       Date:  2005-04       Impact factor: 2.153

10.  Can Enterococcal Infections Initiate Sepsis Syndrome?

Authors:  Peter Linden
Journal:  Curr Infect Dis Rep       Date:  2003-10       Impact factor: 3.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.